-
-
-
-
-
-
-
Fate Therapeutics (FATE) PT Lowered to $4 at Baird
-
-
-
-
-
-
-
Fate Therapeutics (FATE) Tops Q2 EPS by 13c
-
-
-
-
-
-
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
-
-
-
-
-
-
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
-
-
-
-
-
-
-
Fate Therapeutics (FATE) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2022 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

